home / stock / hegiy / hegiy news
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Hengan International Group Co. Ltd. ADR (HEGIY) is expected to report for Q4 2023
2023-09-14 15:08:44 ET More on Hengan International Group Company Limited Historical earnings data for Hengan International Group Company Limited Dividend scorecard for Hengan International Group Company Limited Financial information for Hengan International Group Co...
Chinese stocks are in the spotlight of many investors right now. While the US tech giants are rushing from record to record, Chinese competitors have literally crashed in recent months. The ongoing activities by the Chinese government and authorities as well as the associated reg...
Hengan appears to be a real gem. A dividend yield of almost 6 percent and a massive undervaluation are increasingly attracting cash flow-oriented dividend hunters. Assuming a P/E of 15 and a KCV of 12 as multiples for a fair value, we see an upside potential of 63 percent based on...
News, Short Squeeze, Breakout and More Instantly...
Hengan International Group Co Ltd ADR Company Name:
HEGIY Stock Symbol:
OTCMKTS Market:
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Hengan International Group Co. Ltd. ADR (HEGIY) is expected to report for Q4 2023